ACP
VIVS

Ashfield Capital Partners’s VivoSim Labs VIVS Stock Holding History

Ashfield Capital Partners’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-44
Closed -$28K – 258
2017
Q2 		$28K Hold
44
– – ﹤0.01% 254
2017
Q1 		$33K Hold
44
– – ﹤0.01% 250
2016
Q4 		$36K Buy
+44
New +$34.9K ﹤0.01% 249

Other funds holding VIVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ashfield Capital Partners's VIVS Position: Q3 2017 in Review

Ashfield Capital Partners sold out of VivoSim Labs (VIVS) in Q3 2017, closing a stake of 44 shares — an estimated $28K sold.

Ashfield Capital Partners first reported a position in VIVS in Q4 2016 and held it in 3 quarters. The position peaked at $36K in Q4 2016. 119 funds tracked by Wall St. Rank hold VIVS as of Q3 2017.

  • Ashfield Capital Partners reported no remaining VivoSim Labs position as of Q3 2017 after selling out during the quarter.
  • Ashfield Capital Partners sold 44 VivoSim Labs shares in Q3 2017, an estimated $28K.
  • Ashfield Capital Partners first reported a position in VivoSim Labs in Q4 2016 and held it in 3 quarters.
  • Ashfield Capital Partners's VivoSim Labs position peaked at $36K in Q4 2016.
  • 119 funds tracked by Wall St. Rank held VivoSim Labs as of Q3 2017.

Based on Ashfield Capital Partners's 13F filing for Q3 2017, filed 7 Nov 2017.